Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ASTS | CDE |
|---|---|---|
| Price | $58.44 | $17.05 |
| Change today | ▼ 0.02% | ▼ 3.45% |
| Market cap | $17.52B | $17.53B |
| Return, 3 months | -21.3% | +6.3% |
| Return, year to date | -19.5% | -4.3% |
| Return, 1 year | -19.8% | -11.7% |
| P/E (TTM) | -27.2 | 14.3 |
| P/B | 9.2 | 1.7 |
| P/E percentile vs own 5y | – | 70th |
| Dividend yield | – | 0.12% |
| Revenue growth (YoY, latest qtr) | – | +125.9% |
| Net profit growth (YoY) | – | +72.3% |
| Gross margin | – | 41.8% |
| Operating margin | – | 36.1% |
| Net margin | – | 26.8% |
| Return on equity | – | 12.8% |
| Analyst target vs. price | – | +32.0% |
| Analyst buy share | – | 80% |
| RSI (14) | 45 | 36 |
| 30-day volatility | 70.5% | 51.3% |
| Max drawdown, 1 year | -60.2% | -47.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.